Pharmaceutical Glass Tube Forming With Homogeneous Inner-Surface Leachability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Glass tubes for pharmaceutical containers often exhibit precipitates due to volatile components in the glass composition, leading to variations in alkali leachability and quality issues, resulting in customer dissatisfaction and potential batch discards.

Innovation Solution

A manufacturing process that controls the normalized back diffusion density and temperature at the pipe head during glass tube formation, reducing alkali leachability and achieving homogenous hydrolytic resistance across the inner surface.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If glass tubes are formed by drawing using pipe heads, then glass tubes for pharmaceutical containers can be produced, but precipitates form on the inner surface due to volatile components evaporating and condensing

Engineering Contradiction:
Improveproduction of glass tubesVSAvoidprecipitates on inner surface
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent applies parameter changes by optimizing the glass composition to reduce volatile components and adjusting formation parameters such as drawing speed and temperature to minimize precipitate formation. This resolves the contradiction by modifying the chemical composition and process parameters to eliminate the harmful condensation effect while maintaining production capability.

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If volatile components are present in glass composition, then glass tubes can be formed, but alkali leachability varies across the inner surface leading to quality inconsistencies

Engineering Contradiction:
Improveglass tube formationVSAvoidalkali leachability uniformity
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent changes the chemical parameters of the glass composition by reducing volatile components and adjusting the ratio of oxides. This modification maintains ease of manufacture while significantly improving the uniformity of alkali leachability across the inner surface, resolving the contradiction between manufacturability and quality precision.

Inventive Principle:
Principle #35Parameter changes

3Ease of manufacture

If glass composition contains volatile components, then glass melting and forming is feasible, but technical instabilities occur during manufacturing process

Engineering Contradiction:
Improveglass melting and formingVSAvoidmanufacturing process stability
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent stabilizes the manufacturing process by changing the chemical composition parameters to reduce volatile content. This ensures reliable and stable production conditions while maintaining the feasibility of glass melting and forming operations.

Inventive Principle:
Principle #35Parameter changes

4Object-generated harmful factors

If glass composition is adjusted to reduce precipitates, then alkali leachability improves, but production complexity increases

Engineering Contradiction:
Improvealkali leachabilityVSAvoidmanufacturing process complexity
Core Design Contradiction:
Object-generated harmful factorsVSDevice complexity

Solution Approach 1:

The patent achieves low alkali leachability through optimized glass composition parameters rather than complex manufacturing equipment or processes. This resolves the contradiction by using chemical composition optimization instead of increasing device or process complexity.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process significantly reduces precipitates and variations in alkali leachability, ensuring consistent quality and reducing the risk of batch discards by maintaining low alkali leachability and hydrolytic resistance across the glass tube.

Implementation Method 1

During the hot forming of glass tubes, volatile components evaporate. In the further formation process of the glass tube, the volatile components condense and may form precipitates on the inner surface of the glass tube

Methodology Applied
Scientific EffectEvaporation: Evaporation

Implementation Method 2

During the hot forming of glass tubes, volatile components evaporate. In the further formation process of the glass tube, the volatile components condense and may form precipitates on the inner surface of the glass tube

Methodology Applied
Scientific EffectCondensation: Condensation

Implementation Method 3

tuning a normalised back diffusion density during the manufacturing process for a glass tube

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentEP4186873B1Glass tube for pharmaceutical containers and manufacturing process for a glass tube
Publication Date: 2024.05.08 SCHOTT AG
  • EP4186873B1 patent drawingFigure 1
  • EP4186873B1 patent drawingFigure 2
  • EP4186873B1 patent drawingFigure 3

AI summary

The invention relates to a glass tube for pharmaceutical containers and a manufacturing process for a glass tube. The glass tubes are characterized by a homogenous and low alkali leachability on the inner surface.